ABCD Semaglutide Audit
About the ABCD nationwide semaglutide audit
Exenatide QW significantly improved HbA1c reductions vs exenatide BID at 30 weeks
Authors
Drucker et al
EndoBarrier in 90 consecutively treated patients - Abstract
EndoBarrier treatment for longstanding type 2 diabetes and obesity: outcomes one year after EndoBarr
Meta-analysis
Covid-19 Meta-analysis
